Insider · CIK 0001909680
Barone Francesca
officer
Files at CADL (Candel Therapeutics, Inc.). First filing Dec 3, 2024, latest Mar 20, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $592k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 14Weak | sell 510b5-1 | CADL Candel Therapeutics, Inc. | $282k | 32,146 | -25% | +132% from low · -28% from high | |
| 45Moderate | sell 5 | CADL Candel Therapeutics, Inc. | $98k | 13,534 | -11% | +111% from low · -20% from high | |
| 40Moderate | sell 5 | CADL Candel Therapeutics, Inc. | $112k | 13,673 | -10% | +130% from low · -12% from high | |
| 45Moderate | sell 4 | CADL Candel Therapeutics, Inc. | $101k | 22,081 | -14% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 18, 2025 | CADL Candel Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +18,000 | $1.55 | $28k | 128,673 | Mar 20, 2025 |
| Mar 18, 2025 | CADL Candel Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -32,146 | $8.76 | $282k | 96,527 | Mar 20, 2025 |
| Mar 18, 2025 | CADL Candel Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -18,000 | $0.00 | $0 | 30,822 | Mar 20, 2025 |
| Feb 12, 2025 | CADL Candel Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +115,000 | $0.00 | $0 | 115,000 | Feb 14, 2025 |
| Jan 15, 2025 | CADL Candel Therapeutics, Inc. | SOpen-market sale Common Stock | -13,534 | $7.23 | $98k | 110,673 | Jan 17, 2025 |
| Jan 8, 2025 | CADL Candel Therapeutics, Inc. | SOpen-market sale Common Stock | -13,673 | $8.22 | $112k | 124,207 | Jan 10, 2025 |
| Nov 29, 2024 | CADL Candel Therapeutics, Inc. | SOpen-market sale Common Stock | -22,081 | $4.56 | $101k | 137,880 | Dec 3, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.